These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38066364)

  • 21. Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products.
    Bretaudeau L; Tremblais K; Aubrit F; Meichenin M; Arnaud I
    Front Microbiol; 2020; 11():1161. PubMed ID: 32582101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy.
    Lu TK; Collins JJ
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4629-34. PubMed ID: 19255432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phages for treatment of Salmonella spp infection.
    Baskaran V; Karthik L
    Prog Mol Biol Transl Sci; 2023; 200():241-273. PubMed ID: 37739557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex-dependent differences in behavioral and immunological responses to antibiotic and bacteriophage administration in mice.
    Grabowski Ł; Pierzynowska K; Kosznik-Kwaśnicka K; Stasiłojć M; Jerzemowska G; Węgrzyn A; Węgrzyn G; Podlacha M
    Front Immunol; 2023; 14():1133358. PubMed ID: 37304279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ECOPHAGE: Combating Antimicrobial Resistance Using Bacteriophages for Eco-Sustainable Agriculture and Food Systems.
    García P; Tabla R; Anany H; Bastias R; Brøndsted L; Casado S; Cifuentes P; Deaton J; Denes TG; Islam MA; Lavigne R; Moreno-Switt AI; Nakayama N; Muñoz Madero C; Sulakvelidze A; Svircev AM; Wagemans J; Biosca EG; Rivera D
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental Evolution of the TolC-Receptor Phage U136B Functionally Identifies a Tail Fiber Protein Involved in Adsorption through Strong Parallel Adaptation.
    Burmeister AR; Tzintzun-Tapia E; Roush C; Mangal I; Barahman R; Bjornson RD; Turner PE
    Appl Environ Microbiol; 2023 Jun; 89(6):e0007923. PubMed ID: 37191555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage therapy: delivering on the promise.
    Harper DR; Anderson J; Enright MC
    Ther Deliv; 2011 Jul; 2(7):935-47. PubMed ID: 22833904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophage as an antibacterial agent: a patent perspective.
    Pathak-Vaidya P; Sharma S; Telang M
    Future Microbiol; 2021 Nov; 16():1327-1339. PubMed ID: 34755539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part II: In vitro antimicrobial activity evaluation of a bacteriophage cocktail and several antibiotics.
    Santos TM; Gilbert RO; Caixeta LS; Machado VS; Teixeira LM; Bicalho RC
    J Dairy Sci; 2010 Jan; 93(1):105-14. PubMed ID: 20059909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A first step toward liposome-mediated intracellular bacteriophage therapy.
    Nieth A; Verseux C; Barnert S; Süss R; Römer W
    Expert Opin Drug Deliv; 2015; 12(9):1411-24. PubMed ID: 25937143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous Identification and Susceptibility Determination to Multiple Antibiotics of Staphylococcus aureus by Bacteriophage Amplification Detection Combined with Mass Spectrometry.
    Rees JC; Pierce CL; Schieltz DM; Barr JR
    Anal Chem; 2015 Jul; 87(13):6769-77. PubMed ID: 26016659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages.
    Joerger RD
    Poult Sci; 2003 Apr; 82(4):640-7. PubMed ID: 12710486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biotechnological applications of bacteriophages: State of the art.
    Harada LK; Silva EC; Campos WF; Del Fiol FS; Vila M; Dąbrowska K; Krylov VN; Balcão VM
    Microbiol Res; 2018; 212-213():38-58. PubMed ID: 29853167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phagotherapy in terms of bacteriophage genetics: hopes, perspectives, safety, limitations].
    Krylov VN
    Genetika; 2001 Jul; 37(7):869-87. PubMed ID: 11558226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection.
    Schooley RT; Biswas B; Gill JJ; Hernandez-Morales A; Lancaster J; Lessor L; Barr JJ; Reed SL; Rohwer F; Benler S; Segall AM; Taplitz R; Smith DM; Kerr K; Kumaraswamy M; Nizet V; Lin L; McCauley MD; Strathdee SA; Benson CA; Pope RK; Leroux BM; Picel AC; Mateczun AJ; Cilwa KE; Regeimbal JM; Estrella LA; Wolfe DM; Henry MS; Quinones J; Salka S; Bishop-Lilly KA; Young R; Hamilton T
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28807909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality and safety requirements for sustainable phage therapy products.
    Pirnay JP; Blasdel BG; Bretaudeau L; Buckling A; Chanishvili N; Clark JR; Corte-Real S; Debarbieux L; Dublanchet A; De Vos D; Gabard J; Garcia M; Goderdzishvili M; Górski A; Hardcastle J; Huys I; Kutter E; Lavigne R; Merabishvili M; Olchawa E; Parikka KJ; Patey O; Pouilot F; Resch G; Rohde C; Scheres J; Skurnik M; Vaneechoutte M; Van Parys L; Verbeken G; Zizi M; Van den Eede G
    Pharm Res; 2015 Jul; 32(7):2173-9. PubMed ID: 25585954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel N4-Like Bacteriophage Isolated from a Wastewater Source in South India with Activity against Several Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolates.
    Menon ND; Kumar MS; Satheesh Babu TG; Bose S; Vijayakumar G; Baswe M; Chatterjee M; D'Silva JR; Shetty K; Haripriyan J; Kumar A; Nair S; Somanath P; Nair BG; Nizet V; Kumar GB
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.